These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 37302580

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH.
    Carlin S, Cuker A, Gatt A, Gendron N, Hernández-Gea V, Meijer K, Siegal DM, Stanworth S, Lisman T, Roberts LN.
    J Thromb Haemost; 2024 Sep; 22(9):2653-2669. PubMed ID: 38823454
    [Abstract] [Full Text] [Related]

  • 3. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy.
    Martens K, McMurry HS, Koprowski S, Hum J, Haraga J, Jou JH, Shatzel JJ.
    J Clin Gastroenterol; 2022 Jul 01; 56(6):536-545. PubMed ID: 35537133
    [Abstract] [Full Text] [Related]

  • 4. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis.
    Guerrero A, Campo LD, Piscaglia F, Scheiner B, Han G, Violi F, Ferreira CN, Téllez L, Reiberger T, Basili S, Zamora J, Albillos A, Baveno Cooperation: an EASL consortium.
    J Hepatol; 2023 Jul 01; 79(1):69-78. PubMed ID: 36858157
    [Abstract] [Full Text] [Related]

  • 5. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
    Chun HS, Choe AR, Lee M, Cho Y, Kim HY, Yoo K, Kim TH.
    Clin Mol Hepatol; 2021 Oct 01; 27(4):535-552. PubMed ID: 34130370
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V, Braham S, Tosetti G, Branchi F, Bitto N, Moia M, Fracanzani AL, Colombo M, Tripodi A, Primignani M.
    Clin Gastroenterol Hepatol; 2018 Jul 01; 16(7):1146-1152.e4. PubMed ID: 29066371
    [Abstract] [Full Text] [Related]

  • 8. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M, Erard-Poinsot D, Boillot O, Valette PJ, Guillaud O, Chambon-Augoyard C, Dumortier J.
    Clin Res Hepatol Gastroenterol; 2019 Aug 01; 43(4):395-402. PubMed ID: 30578107
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
    Artaza T, Lopes M, Romero M, Gómez AZ, de la Cruz G, Sánchez JJ, González C, Gómez R.
    Gastroenterol Hepatol; 2018 Dec 01; 41(10):611-617. PubMed ID: 30049580
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study.
    Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, Morard I, Lasser L, Langlet P, Denninger MH, Vidaud D, Condat B, Hadengue A, Primignani M, Garcia-Pagan JC, Janssen HL, Valla D, European Network for Vascular Disorders of the Liver (EN-Vie).
    Hepatology; 2010 Jan 01; 51(1):210-8. PubMed ID: 19821530
    [Abstract] [Full Text] [Related]

  • 15. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
    Loffredo L, Pastori D, Farcomeni A, Violi F.
    Gastroenterology; 2017 Aug 01; 153(2):480-487.e1. PubMed ID: 28479379
    [Abstract] [Full Text] [Related]

  • 16. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I, Vukotic R, Stefanescu H, Pecorelli A, Morelli M, Grigoras C, Sparchez Z, Andreone P, Piscaglia F, BO-LIVES (BOlogna LIVEr vascular Studies).
    Am J Gastroenterol; 2019 Feb 01; 114(2):258-266. PubMed ID: 30538290
    [Abstract] [Full Text] [Related]

  • 17. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M, M Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, A Burroughs K.
    Liver Int; 2012 Jul 01; 32(6):919-27. PubMed ID: 22435854
    [Abstract] [Full Text] [Related]

  • 18. [Complexities and challenges in the management of portal vein thrombosis in cirrhosis].
    Chu HK, Chen LY, Yang L.
    Zhonghua Gan Zang Bing Za Zhi; 2021 Mar 20; 29(3):196-198. PubMed ID: 33902183
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
    Delgado MG, Seijo S, Yepes I, Achécar L, Catalina MV, García-Criado A, Abraldes JG, de la Peña J, Bañares R, Albillos A, Bosch J, García-Pagán JC.
    Clin Gastroenterol Hepatol; 2012 Jul 20; 10(7):776-83. PubMed ID: 22289875
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.